.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent Right to Information (RTI) data reveals that the National Immunisation Programme faces persistent financial underutilization. Although the Indian government allocates thousands of crores annually, a significant portion remains unspent by state health departments. Consequently, this creates questions regarding the implementation efficiency of one of the world's largest public health initiatives. Doctors and public health experts must understand these fiscal trends to advocate for better resource management at the ground level.
Budgetary data for the 2024-25 period shows a sanctioned amount of Rs 3,186 crore, yet actual expenditure was only Rs 1,971 crore. This trend appears to persist into the 2025-26 fiscal year. Provisional figures indicate that only Rs 1,060 crore has been utilized against a sanctioned Rs 3,434 crore. These gaps often arise from fragmented record-keeping and delays in state-level monitoring reports. Therefore, streamlining data systems is essential for improving financial accountability and service delivery.
Despite financial hurdles, India has achieved remarkable success in expanding its reach. Full immunisation coverage surged from 88.2% in 2021-22 to 98.1% by 2024-25. Furthermore, approximately 2.5 crore children receive life-saving vaccines annually against diseases like polio and hepatitis B. However, experts suggest that the programme should expand to include typhoid and influenza vaccines. Additionally, improving gender-specific data collection will help ensure that no child is left behind due to systemic gaps.
Q1: Which vaccines are provided for free under India's national programme?
The programme offers free protection against multiple diseases, including polio, measles, hepatitis B, and tuberculosis. It aims to protect approximately 26 million newborns annually.
Q2: Why is the full expenditure of sanctioned funds often delayed?
Delays often occur due to fragmented data reporting from states and UTs. Furthermore, administrative bottlenecks in monitoring and procurement can lead to significant portions of the budget remaining unspent.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
RTI data reveals significant unspent funds in India's National Immunisation Programme despite a 98.1% coverage rate, highlighting implementation challenges....
6 months ago
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today
In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
